Lantus vs toujeo

Toujeo (insulin glargine) vs Lantus and Levemir Toujeo is a concentrated form of long-acting insulin with the same active ingredient as Lantus that has been approved since 2024. However, instead of the normal 100 units per milliliter concentration, Toujeo is 300 units per milliliter, making it more concentrated compared to Lantus.

of insulin glargine from the Toujeo precipitate compared to LANTUS. Glucose Toujeo compared to LANTUS-treated patients. The superiority of Toujeo

For plans that currently cover Levemir: Lantus, Lantus SoloStar, Toujeo SoloStar, Toujeo Max SoloStar, Tresiba, and Tresiba FlexTouch. For

insulin aspart (NovoLog) insulin glargine (Basaglar KwikPen, Lantus, Lantus OptiClik Cartridge, Lantus Solostar Pen, Toujeo Max Solostar, Toujeo SoloStar).

Hypoglycemic events with Lantus vs Tresiba in T1DM, JAMA (2024) [PubMed abstract] Lantus, Toujeo, Admelog, Apidra, Sanofi Insulin Value Savings Program.

insulin glargine (Basaglar KwikPen, Lantus, Lantus OptiClik Cartridge, Lantus Solostar Pen, Toujeo Max Solostar, Toujeo SoloStar)

Toujeo works out only slightly more expensive than Lantus if you take the fact that it is three times more concentrated into consideration (real cost value $30.76/mL with Toujeo vs $30.23/mL with Lantus).

Long acting insulin - Lantus, Levemir, Abasaglar, Tresiba Toujeo Lantus vs. Toujeo: The difference between these two types of insulin

LS mean difference for Toujeo vs. insulin degludec 100 units/mL of -0.05 Compared to Lantus, Toujeo demonstrated: A 31% lower (RR 0.69 [95